Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Assessment of the hematological profile of children with chronic kidney disease on follow-up at St. Paul’s Hospital Millennium Medical College and Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia

Authors: Melaku Shenkut, Fekadu Urgessa, Rahel Alemu, Bezaye Abebe

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is a major public health issue with an increasing incidence and prevalence worldwide. In CKD, hematological parameters are influenced, and the effect increases with CKD stage. Thus, the aim of this study was to assess hematological profile of children with CKD on follow up at Tikur Anbessa Specialized Hospital and St. Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia.

Methods

A cross-sectional study was carried out from March 1 to June 30, 2021 among 238 children with CKD. EDTA tubes were used to collect 4 ml blood samples, which were then examined by Beckman Coulter automated hematology analyzer. SPSS Version 20 was used for statistical analysis, and a bivariate and multivariate regression model were applied to assess correlations. Mean and standard deviation was used to determine hematological profiles.

Results

The total number of patients in the study were 238, with 42 (59.7%) of them being men. The majority of the patients (81%) had CKD stage 1. Mean ± standard deviation determined for white blood cell (WBC) parameters in (thousand/µL); WBC, Neutrophil, Lymphocytes, Eosinophil, Monocytes and Basophil were 8.93 ± 3.32, 4.6 ± 8.31, 2.79 ± 1.62, 0.31 ± 0.51, 0.50 ± 3.03 and 0.03 ± 0.24, respectively. For some of red blood cell (RBC) parameters; RBC (million/ µL), Hemoglobin (Hgb) (g/dL), Hematocrit (Hct) (%) and Mean cell volume (fl.) were 4.73 ± 0.87, 12.82 ± 2.76, 38.28 ± 7.53 and 80.32 ± 7.89, respectively. For the platelet count (PLT) (thousand/µL) and Mean Platelet volume (MPV) (fL) 349.34 ± 130.18 and 9.03 ± 4.31 were determined, respectively. This study also found hematologic parameters such as RBC, HGB, HCT and MPV were found to be positively correlated with eGFR with a P-value < 0.05 for all parameters.

Conclusion

The study found that the majority of study participants were in stages 1 to 3 based on their estimated glomerular filtration rate (eGFR). Some of hematological parameters found to have positive correlation with eGFR. There is a need to improve multiple aspects of CKD management, including routine hematological tests for children with chronic kidney disease.
Literature
1.
go back to reference Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem. Approaches and initiatives – a position statement from kidney disease improving global outcomes. Kidney Int. 2007;7 2:247–59.CrossRef Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem. Approaches and initiatives – a position statement from kidney disease improving global outcomes. Kidney Int. 2007;7 2:247–59.CrossRef
2.
go back to reference Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.CrossRefPubMed Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.CrossRefPubMed
3.
go back to reference Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition, and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.CrossRefPubMed Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition, and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.CrossRefPubMed
4.
go back to reference George SV, Kumar SS, Mukadan JK, Pullockara JK. A study to assess changes in the hematological profile in chronic kidney disease. Pharm Innov. 2015;4(6):1–3. George SV, Kumar SS, Mukadan JK, Pullockara JK. A study to assess changes in the hematological profile in chronic kidney disease. Pharm Innov. 2015;4(6):1–3.
5.
go back to reference Strazdins V, Stefanidis V, Watson AR, Harvey B. Renal replacement therapy for acute renal failure in children. Eur Guidelines Paediatric Nephrol. 2014;19:199–207.CrossRef Strazdins V, Stefanidis V, Watson AR, Harvey B. Renal replacement therapy for acute renal failure in children. Eur Guidelines Paediatric Nephrol. 2014;19:199–207.CrossRef
6.
go back to reference Olowu WA, Adelusola KA. Pediatric acute renal failure in southwestern Nigeria. Kidney Int. 2012;66:1541–8.CrossRef Olowu WA, Adelusola KA. Pediatric acute renal failure in southwestern Nigeria. Kidney Int. 2012;66:1541–8.CrossRef
7.
go back to reference Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Association of mortality and hospitalization with the achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J Am Soc Nephrol. 2008;17:2878–85.CrossRef Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Association of mortality and hospitalization with the achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J Am Soc Nephrol. 2008;17:2878–85.CrossRef
8.
go back to reference Warady BA, Ho M. Morbidity and mortality in children with anemia at the initiation of dialysis. Pediatr Nephrol. 2011;18:1055–62.CrossRef Warady BA, Ho M. Morbidity and mortality in children with anemia at the initiation of dialysis. Pediatr Nephrol. 2011;18:1055–62.CrossRef
9.
go back to reference Halle MP, Takongue C, Kengne AP, Kaze FF, Ngu KB. Epidemiological profile of patients with end-stage renal disease in a referral hospital in Cameroon. BMC Nephrol. 2015;16:59–64.CrossRefPubMedPubMedCentral Halle MP, Takongue C, Kengne AP, Kaze FF, Ngu KB. Epidemiological profile of patients with end-stage renal disease in a referral hospital in Cameroon. BMC Nephrol. 2015;16:59–64.CrossRefPubMedPubMedCentral
10.
go back to reference Shaheen FAM, Souqiyyeh MZ, Al-Attar BA, Karkar A, Jazairi AMH, Badawi LS, et al. Prevalence of anaemia in predialysis chronic kidney disease patients. Saudi J Kidney Dis Transpl. 2011;22(3):456–63.PubMed Shaheen FAM, Souqiyyeh MZ, Al-Attar BA, Karkar A, Jazairi AMH, Badawi LS, et al. Prevalence of anaemia in predialysis chronic kidney disease patients. Saudi J Kidney Dis Transpl. 2011;22(3):456–63.PubMed
11.
go back to reference Lorber DL, Provenzano R, McClellan W. Prevalence and treatment of anemia with once weekly epoetin alfa in patients with diabetes and chronic kidney disease. Endocr Pract. 2006;12(5):506–13.CrossRefPubMed Lorber DL, Provenzano R, McClellan W. Prevalence and treatment of anemia with once weekly epoetin alfa in patients with diabetes and chronic kidney disease. Endocr Pract. 2006;12(5):506–13.CrossRefPubMed
12.
go back to reference Kinchen KS, Sadler J, Fink N, Klag MJ, Levey AS, Powe NR. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137(6):479–86.CrossRefPubMed Kinchen KS, Sadler J, Fink N, Klag MJ, Levey AS, Powe NR. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137(6):479–86.CrossRefPubMed
13.
go back to reference Wong H, Mylrea K, Feber J, Drukker A, Filler G. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int. 2006;70:585–90.CrossRefPubMed Wong H, Mylrea K, Feber J, Drukker A, Filler G. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int. 2006;70:585–90.CrossRefPubMed
14.
go back to reference Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia. Third Natl Health Nutr Examination Surv. 2012;23(2):312–97. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia. Third Natl Health Nutr Examination Surv. 2012;23(2):312–97.
15.
go back to reference Warady BA, Ho M. PaediatricNephrol. Morbidity and mortality in children with anemia at the initiation of dialysis. Clin J Am Soc Nephro. 2003;18:1055–62. Warady BA, Ho M. PaediatricNephrol. Morbidity and mortality in children with anemia at the initiation of dialysis. Clin J Am Soc Nephro. 2003;18:1055–62.
16.
go back to reference Afshar R, Sanavi S, Salimi J, Ahmad Zadeh M. Hematological profile of chronic kidney disease patients in Iran, in pre-dialysis stages and after initiation of hemodialysis. Saudi J Kidney Dis Transpl. 2010;21(2):368–71.PubMed Afshar R, Sanavi S, Salimi J, Ahmad Zadeh M. Hematological profile of chronic kidney disease patients in Iran, in pre-dialysis stages and after initiation of hemodialysis. Saudi J Kidney Dis Transpl. 2010;21(2):368–71.PubMed
17.
go back to reference Callegari J, Antwi S, Wystrychowski G, Zukowska-Szczechowska E, Levin NW, Carter M. Peritoneal dialysis as a mode of treatment for acute kidney injury in sub-Saharan Africa. Blood Purif. 2013;36:226–300.CrossRefPubMed Callegari J, Antwi S, Wystrychowski G, Zukowska-Szczechowska E, Levin NW, Carter M. Peritoneal dialysis as a mode of treatment for acute kidney injury in sub-Saharan Africa. Blood Purif. 2013;36:226–300.CrossRefPubMed
Metadata
Title
Assessment of the hematological profile of children with chronic kidney disease on follow-up at St. Paul’s Hospital Millennium Medical College and Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia
Authors
Melaku Shenkut
Fekadu Urgessa
Rahel Alemu
Bezaye Abebe
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03464-7

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.